Expertise Publication

Pandemic influenza: A 21st century model for mortality shocks

Since the catastrophic pandemic in 1918, there have been various medical developments – in particular antibiotics, vaccines and antivirals – along with changes in the way that individuals and authorities respond to a pandemic threat. This makes it difficult for life insurers to quantify the potential loss value arising from the risk and therefore difficult to manage their capital efficiently for the benefit of both policyholders and shareholders. This technical publishing brochure forms a key pillar of Swiss Re’s contribution to industry dialogue on the impact of an influenza pandemic on life insurance business.

Language Versions